Chinese Journal of Multiple Organ Diseases in the Elderly · Nov 11, 2026

Effects and underlying mechanisms of semaglutide in rats with diabetic cognitive impairment

By Li Hongju, Xue Jun

Objective To investigate the effect of semaglutide on diabetic cognitive impairment (DCI) in rats and the underlying mechanisms involving the PI3K/Akt/GSK-3β signaling pathway. Methods Rats with DCI were randomly assigned to a normal control (NC) group, a model (Mod) group, a semaglutide (Sema) group, and an acarbose (Aca) group. After 6 weeks of intervention, levels of glucose metabolism indicators and inflammatory cytokines were measured, hippocampal histology was examined using HE staining, learning and memory abilities were assessed, and molecules associated with the PI3K/Akt/GSK-3β signaling pathway were detected in these groups. SPSS statistics 29.0 and GraphPad Prism 8.0 were used for statistical analysis and plotting. Data comparison between two groups was performed using student′s t test, Tukey test or one-way ANOVA depending on data type. Results Compared with the Mod group, the Sema group exhibited significant decreases in random blood glucose levels, area under the glucose tolerance curve, homeostasis model assessment of insulin resistance, and interleukin 6 level (P<0.05), whereas the level of anti-inflammatory factor IL-10 was significantly increased (P<0.05). In the Sema group, the structure of hippocampal neurons was preserved, with the cells orderly arranged and reduced neuronal damage and cell apoptosis. Morris water maze test showed that, compared with the Mod group, the Sema group had a significantly shorter escape latency (P<0.05) and an increased number of platform crossings (P<0.05). Reverse transcription quantitative real-time PCR revealed that the mRNA expression levels of PI3K, Akt, and GSK-3β in hippocampal tissues were significantly higher in the Sema group than in the Mod group (all P<0.05). Western blotting results demonstrated that the protein expression levels of p-PI3K, p-Akt, and p-GSK-3β were significantly elevated in the Sema group than in the Mod group (all P<0.05). Conclusion Semaglutide can alleviate hippocampal tissue damage and improve cognitive function in DCI rats by activating the PI3K/Akt/GSK-3β pathway.

The paperJournal siteInterventions

AgingResearch.News